ARIA News Alert Ariad Pharmaceuticals (ARIA) 6.81 12/25/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ariad Pharmaceuticals (ARIA) 6.81 $ARIA

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Dec 23, 8:18AM CST

CYTK: 5.87 (+0.35), JRJC: 5.81 (-0.11), RDN: 16.78 (+0.18), CHK: 19.84 (-0.45), VNDA: 14.69 (+1.11), DRL: 3.38 (-0.02), ARIA: 6.81 (+0.15), ICLD: 3.00 (-0.02), NQ: 4.32 (-0.36)

Ariad Pharma inks commercialization deal in Asia
Seeking Alpha - at Seeking Alpha - Tue Dec 23, 6:43AM CST

ARIA: 6.81 (+0.15)

ARIAD and Otsuka Announce Co-Development and Commercialization Agreement for Iclusig to Treat Leukemias in Japan and Nine Other Asian Countries
Business Wire - Tue Dec 23, 6:00AM CST
--Otsuka to obtain rights in ten Asian countries to Iclusig, a newest-generation treatment for patients with refractory chronic myeloid leukemia and Ph+ acute lymphoblastic leukemia
ARIA: 6.81 (+0.15)

ARIAD To Present at The 33rd Annual J.P. Morgan Healthcare Conference
Business Wire - Mon Dec 22, 6:35AM CST
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will present at the 33rd Annual J.P. Morgan Healthcare Conference being held in San Francisco. Harvey J. Berger, M.D., chairman and chief executive officer, will provide an overview of the Company's business on Wednesday, January 14 at 3:00 p.m. (PT).
JPM: 62.48 (unch), ARIA: 6.81 (+0.15)

Adam Feuerstein's 2014 Biotech Stock Report Card (No Grading on a Curve)
at The Street - Fri Dec 19, 8:02AM CST
Good calls: Vertex, InterMune, Chelsea, Galena, Exact Sciences. The bad calls: Avanir, Amarin, Exelixis and the bursting biotech stock bubble.
VRTX: 115.15 (+1.40), GALE: 1.49 (-0.02), EXAS: 27.60 (+0.39), ARIA: 6.81 (+0.15), MNKD: 5.68 (+0.18)

Biotech Stocks Technical Insight -- ARIAD Pharma, Geron, PDL BioPharma, Cytori Therapeutics, and Navidea Biopharma
PR Newswire - Thu Dec 18, 8:15AM CST
Investor-Edge has initiated coverage on the following equities: ARIAD Pharmaceuticals Inc. (NASDAQ: ARIA), Geron Corporation (NASDAQ: GERN), PDL BioPharma Inc. (NASDAQ: PDLI), Cytori Therapeutics Inc. (NASDAQ: CYTX), and Navidea Biopharmaceuticals Inc. (NYSE MKT: NAVB). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Wednesday, December 17, 2014, surged as the Dow Jones Industrial Average finished at 17,356.87, up 1.69% and the NASDAQ Composite closed at 4,644.31, up 2.12%. The S&P 500 finished the session 2.04% higher at 2,012.89. During the trading session, all the ten sectors finished on a higher note. The S&P 500 Health Care Index ended the day at 791.66, up 1.90%, with the index advancing 6.28% in the previous three months. Register for your complimentary reports on these five stocks at:
NAVB: 2.00 (+0.02), CYTX: 0.48 (-0.01), GERN: 3.06 (+0.05), ARIA: 6.81 (+0.15), PDLI: 7.61 (unch)

Does George Soros Think Biotech's Bull Run Is Finally Coming to an End?
George Budwell, The Motley Fool - Motley Fool - Mon Dec 15, 6:45AM CST
To say that biotech stocks have performed well as a group over the last two years is an understatement; they have absolutely crushed the broader markets. For example, the iShares Nasdaq Biotech Index has more than tripled the performance of the ...
SRPT: 13.88 (+0.47), IBB: 299.80 (+5.12), ARIA: 6.81 (+0.15), CELG: 109.60 (+3.48)

SmarTrend Watching for Potential Rebound in Shares of Ariad Pharmaceuticals After 7.76% Loss
Comtex SmarTrend(R) - Thu Dec 11, 4:40PM CST
Ariad Pharmaceuticals (NASDAQ:ARIA) traded in a range yesterday that spanned from a low of $6.34 to a high of $6.88. Yesterday, the shares fell 7.8%, which took the trading range below the 3-day low of $6.80 on volume of 13.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ARIA: 6.81 (+0.15)

Energy Stocks Pare Gains as Crude Oil Closes Below $60 For First Time in Five Years
at The Street - Thu Dec 11, 1:52PM CST
Energy stocks are leading the markets higher, a day after they sparked a selloff.
SPLS: 17.82 (-0.01), DAL: 48.05 (+0.92), XOM: 93.78 (-0.81), COP: 70.13 (-0.92), LLY: 70.16 (+0.42), LULU: 54.40 (-0.16), LUV: 41.66 (+0.68), URBN: 34.15 (-0.53), EBAY: 57.10 (-0.12), AAL: 51.43 (+1.22), ODP: 8.75 (+0.06), ARIA: 6.81 (+0.15), CVX: 113.47 (-0.48), WAG: 76.67 (+0.16), XLE: 80.13 (-0.59)

Nasdaq stocks posting largest percentage decreases
AP - Thu Dec 11, 12:19PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
AMBA: 52.05 (+0.72), LNCO: 10.87 (-0.44), MCEP: 6.07 (-0.12), LAKE: 8.94 (+0.07), CLDN: 18.54 (+0.85), BRID: 7.01 (-0.45), ARIA: 6.81 (+0.15), LINE: 10.93 (-0.32), MIND: 5.77 (+0.14), DGLY: 15.62 (+0.82), ALLT: 9.28 (+0.15), ROSE: 23.18 (-0.45)

Ariad slumps after analyst downgrade
Seeking Alpha - at Seeking Alpha - Thu Dec 11, 9:25AM CST

IBB: 299.80 (+5.12), ARIA: 6.81 (+0.15)

Will Ariad Pharmaceuticals (ARIA) Stock be Affected Today by This Analyst Action?
at The Street - Thu Dec 11, 8:14AM CST
Shares of Ariad Pharmaceuticals (ARIA) are down after Credit Suisse downgraded the global oncology company to 'underperform' from 'neutral' and lowered its price target to $6 from $8.
ARIA: 6.81 (+0.15)

Downgrade Alert for Ariad Pharmaceuticals (ARIA)
Comtex SmarTrend(R) - Thu Dec 11, 6:54AM CST
Ariad Pharmaceuticals (NASDAQ:ARIA) was downgraded from Neutral to Underperform at Credit Suisse today. The stock closed yesterday at $7.02 on volume of 4.6 million shares, below average daily volume of 6.3 million. In the past 52 weeks, Ariad Pharmaceuticals share prices have been bracketed by a low of $3.80 and a high of $9.83 and closed yesterday at $7.02, 85% above that low price. Over the last five market days, the 200-day moving average (MA) has gone down 0.3% while the 50-day MA has advanced 1.5%.
ARIA: 6.81 (+0.15)

Uptrend Call Working As Ariad Pharmaceuticals Stock Rises 22.6% (ARIA)
Comtex SmarTrend(R) - Tue Dec 09, 5:08PM CST
SmarTrend identified an Uptrend for Ariad Pharmaceuticals (NASDAQ:ARIA) on October 29th, 2014 at $5.92. In approximately 1 month, Ariad Pharmaceuticals has returned 22.57% as of today's recent price of $7.25.
ARIA: 6.81 (+0.15)

Long-term follow up data for Iclusig positive
Seeking Alpha - at Seeking Alpha - Tue Dec 09, 9:54AM CST

ARIA: 6.81 (+0.15)

ARIAD Announces Follow-up Data from Phase 1 and PACE Trials of Ponatinib in Patients with T315I Mutation in Chronic Myeloid Leukemia
Business Wire - Tue Dec 09, 6:35AM CST
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced safety and efficacy follow-up data on Iclusig(R) (ponatinib), its approved BCR-ABL inhibitor, in patients with a baseline T315I mutation from its Phase 1 and Phase 2 PACE trials in heavily pretreated patients with resistant or intolerant chronic myeloid leukemia (CML) or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
ARIA: 6.81 (+0.15)

ARIAD Announces Long-Term Safety and Efficacy Data of Ponatinib in Chronic-Phase Chronic Myeloid Leukemia from Phase 1 Clinical Trial
Business Wire - Tue Dec 09, 6:35AM CST
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced long-term follow up data from the Phase 1 trial of Iclusig(R) (ponatinib), its approved BCR-ABL inhibitor, in heavily pretreated patients with resistant or intolerant chronic myeloid leukemia (CML) or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). The study now shows that with a median follow-up of four years in chronic phase CML (CP-CML) patients, Iclusig continues to demonstrate anti-leukemic activity in patients with limited treatment options and that responses have been maintained in CP-CML patients (n=43) with 72 percent having a major cytogenetic response (MCyR), 65 percent having a complete cytogenetic response (CCyR) and 56 percent having a major molecular response (MMR). Long-term safety data show that careful benefit-risk evaluations should guide decisions to use and maintain ponatinib therapy, particularly in patients who may be at increased risk for arterial thrombotic events.
ARIA: 6.81 (+0.15)

ARIAD Announces Long-Term Safety and Efficacy Data of Ponatinib from Phase 2 Pace Clinical Trial
Business Wire - Mon Dec 08, 6:35AM CST
ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) today announced long-term follow up from its pivotal Phase 2 trial of Iclusig(R) (ponatinib), its approved BCR-ABL inhibitor, in heavily pretreated patients with resistant or intolerant chronic myeloid leukemia (CML) or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). The study now shows that with a median follow-up of approximately 3 years for chronic-phase CML (CP-CML) patients in the trial, Iclusig continues to demonstrate anti-leukemic activity in patients with limited treatment options. Deep and durable responses have been maintained in CP-CML patients with 83 percent of CP-CML patients who achieved a response, estimated to remain in major cytogenetic response (MCyR) at three years.
ARIA: 6.81 (+0.15)

Why Ariad Pharmaceuticals, Inc. Stock Catapulted 19% Higher in November
Sean Williams, The Motley Fool - Motley Fool - Fri Dec 05, 7:36AM CST
ARIA data by YCharts What: Shares of Ariad Pharmaceuticals , a biopharmaceutical company focused on developing therapies to treat cancer, surged by 19% in November according to data from S&P Capital IQ after reporting market-topping...
ARIA: 6.81 (+0.15)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dario’s Second Women’s Health Win Tests Expansion Case

Updated Category News Views 89

Midlife care just became the newest proving ground for DarioHealth’s sales pitch. The company says The Minnesota Star Tribune has expanded its existing relationship to include Dario Women™, a program for employees navigating perimenopause and menopause. Eligible employees are expected to gain access in January 2027. For NASDAQ:DRIO, this is not some grand revenue...

Continue Reading
Hyster-Yale's $125 Million Convertible Debt Shuffle

Updated Category News Views 142

Forklifts do not make headlines often, but debt terms sure can. Hyster-Yale has proposed a $125 million private offering of convertible senior notes due November 15, 2031, with buyers able to take another $18.75 million if the initial purchasers exercise their option. For NYSE:HY holders, this is not a victory lap or a distress flare by itself. It is a refinancing...

Continue Reading
Housing's Value Equation Is Getting More Complicated

Updated Category News Views 91

A homeowner's insurance bill has become a louder market signal than a granite countertop. Green Builder Media's latest batch of research, publishing and events is aimed squarely at that uncomfortable truth: housing is no longer judged only by the price on the contract. Buyers, builders, lenders and insurers are being pushed to reckon with what a home costs to own, protect...

Continue Reading
Miami Office Puts Dubai Closer to U.S. Business Deal Flow

Updated Category News Views 11

Miami is not a random pin on a map; it is a deliberate front door to the Americas, and Dubai International Chamber has decided it needs someone standing in it. The chamber opened a representative office there on November 19, 2026, its second in the United States after launching in New York during the Dubai Business Forum – USA in November 2025. This is not the sort of...

Continue Reading
Thanksgiving Dog Safety Is a Pet Care Reality Check

Updated Category News Views 103

A crowded Thanksgiving kitchen can turn a well-behaved dog into a scavenger with lousy odds. Camp Bow Wow’s holiday guidance is not pretending the meal itself is the problem; the trouble is that a house full of distracted people, rich food and unsecured trash creates a pile of easy mistakes. For pet owners, that is a fair reminder. For anybody watching the pet-care...

Continue Reading
Happiest Minds Extends Absa Banking Platform Reach

Updated Category News Views 34

Mauritius just handed Happiest Minds a useful, if modest, banking-tech scorecard. On November 19, 2026, the company said its cloud-native Arttha platform had been deployed to support selected capabilities within Spark by Absa, a digital banking and lifestyle app from Absa Bank (Mauritius). This is not the sort of announcement that lets anybody pencil in a giant revenue...

Continue Reading
Marina del Rey's Travel Award Brings Fresh Attention

Updated Category News Views 86

A harbor town just got handed a useful little megaphone. On November 18, 2026, the Marina del Rey Tourism Board said Marina del Rey had been selected as a winner in Good Housekeeping's 2027 Travel Awards. That is not a quarterly earnings event, and nobody ought to dress it up as one. Still, in the visitor economy, recognition from a broad consumer publication can matter...

Continue Reading
Valley Family Health Breach Notice Raises Hard Questions

Updated Category News Views 68

Seven months is a long time for sensitive patient data to sit inside an unresolved security story. Valley Family Health Care, Inc. says it suffered a network disruption on or about March 13, 2026, investigated with outside cybersecurity specialists, and ultimately determined that an unauthorized actor accessed and acquired certain files. The formal notification process...

Continue Reading
CHN Energy's Indonesia Record Deserves a Hard Look

Updated Category News Views 5

Twenty years of boots sinking into swamp mud tells a sturdier story than a polished anniversary slogan. CHN Energy says it entered Indonesia's energy market two decades ago and has since built an operating presence around reliable electricity, local training and community work. In a country scattered across thousands of islands, dependable power is not some decorative...

Continue Reading
A €18 Million Mecca Chandelier Tests Austrian Craft

Updated Category News Views 229

Scale Is Easy to Boast About, Delivery Is Not A 34.1-metre chandelier hanging in Mecca is the sort of job that makes ordinary project talk sound downright silly. Lights of Vienna says it designed, built, tested, shipped and installed this monster for the Grand Mosque's Shamiya area, with a contract value of roughly €18 million. That is a serious piece of work for a...

Continue Reading

Top 5 Most Recently Viewed Articles

Stock Market Sees Notable Gains with Various Companies Rising

Updated Category News Views 165

U.S. Stocks Surge With Promising Developments The U.S. stock market experienced a significant uptick recently, highlighted by the Dow Jones index increasing over 200 points. This positive momentum was driven by various companies showcasing impressive stock gains during the trading day. Olo Inc.: A Leap Forward Olo Inc. (NYSE: OLO) garnered considerable attention as its...

Continue Reading
CACI International Welcomes New Board Member Scott Morrison

Updated Category News Views 220

Scott C. Morrison Joins CACI International's Board CACI International Inc (NYSE: CACI) has recently announced that Scott C. Morrison has joined its Board of Directors. This strategic appointment is effective immediately and highlights CACI's commitment to enhancing its leadership with experienced professionals. Morrison, recognized for his vast financial expertise, will...

Continue Reading
Frontera Energy's Q2 Report: Key Insights and Figures

Updated Category News Views 235

Frontera Energy Reports Second Quarter 2025 Results Key Financial Highlights: Frontera Energy Corporation (TSX: FEC) has reported significant financial outcomes for the second quarter of 2025. The company recorded a net loss of $455.2 million, primarily due to non-cash impairment charges tied to its interests in various assets. Despite the challenges, total production...

Continue Reading
Investigation Launched for Bank of Montreal Investors' Rights

Updated Category News Views 57

Bank of Montreal Investors Under Review Pomerantz LLP has initiated an investigation focused on potential claims that may impact investors of Bank of Montreal, recognized by its stock symbol BMO (NYSE: BMO). The firm is urging individuals who have invested in the company to come forward and discuss their concerns. With a commitment to protecting investor rights, Pomerantz...

Continue Reading
Hard Rock International and Seminole Gaming's Ocean Initiative

Updated Category News Views 240

Hard Rock International and Seminole Gaming Unite for Sustainability A global effort resulted in the collection of over 6,400 lbs. of waste, engaging more than 1,700 participants from various countries and communities. This initiative illustrates the commitment of Hard Rock International and Seminole Gaming to environmental stewardship through the Global Sound Waves...

Continue Reading